Clinical trial

Protective Role of Inhaled Steroids for Covid-19 Infection

NCT04331054

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2020-04-13

PhasePHASE3

Study timeline

Study start (actual)2020-04-13Date precision: day

Registry last updated2021-08-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Covid-19 Infectionunresolved

Hospitalization in Respiratory Disease Departmentunresolved

Interventions

2: Usual practice + SYMBICORT RAPIHALERDRUG

1: Usual practiceOTHER

Sponsors & collaborators

Assistance Publique - Hôpitaux de Parislead sponsor

Mapped research locations

ParisFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04331054 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.